These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8996547

  • 1. Leukocyte alkaline phosphatase and serum alkaline phosphatase in patients with metastatic breast and colon cancer.
    Walach N, Gur Y.
    Neoplasma; 1996; 43(5):297-300. PubMed ID: 8996547
    [Abstract] [Full Text] [Related]

  • 2. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M, Bonneterre J, Hecquet B, Desoize B, Demaille A.
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [Abstract] [Full Text] [Related]

  • 3. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
    Walach N, Guterman A, Zaidman JL, Scharf S, Weinberger L, Kaufman S.
    Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of bone and tumour markers in patients with malignant diseases.
    Oremek GM, Weis A, Sapoutzis N, Sauer-Eppel H.
    Anticancer Res; 2003; 23(2A):987-90. PubMed ID: 12820336
    [Abstract] [Full Text] [Related]

  • 5. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
    Wolff JM, Ittel TH, Borchers H, Boekels O, Jakse G.
    Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK.
    J Pharm Biomed Anal; 2004 Mar 01; 34(4):827-32. PubMed ID: 15019061
    [Abstract] [Full Text] [Related]

  • 8. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B, Veiler V, Pourny C, Comoe L, Jardillier JC.
    Anticancer Res; 1989 Mar 01; 9(4):1105-9. PubMed ID: 2817792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Leukocyte alkaline phosphatase and carcinoembryonic antigen in metastatic colorectal cancer patients.
    Walach N, Guterman A, Zaidman JL, Kaufman S, Weimberger L, Scharf S.
    Tumori; 1991 Apr 30; 77(2):164-6. PubMed ID: 2048230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
    Bensouda Y, André F, Boulet T, Al-Ghuzlan A, Conforti R, Troalen F, Bourgier C, Errihani H, Spielmann M, Delaloge S.
    Bull Cancer; 2009 Oct 30; 96(10):923-8. PubMed ID: 19696005
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of elevated serum alkaline phosphatase levels preoperatively in patients with carcinoma of the colon and rectum.
    Tartter PI, Slater G, Papatestas AE, Aufses AH.
    Surg Gynecol Obstet; 1984 Jun 30; 158(6):569-71. PubMed ID: 6729678
    [Abstract] [Full Text] [Related]

  • 15. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
    Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L.
    Endocr Relat Cancer; 2005 Mar 30; 12(1):109-17. PubMed ID: 15788643
    [Abstract] [Full Text] [Related]

  • 16. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
    Voorzanger-Rousselot N, Journe F, Doriath V, Body JJ, Garnero P.
    Calcif Tissue Int; 2009 May 30; 84(5):348-54. PubMed ID: 19252761
    [Abstract] [Full Text] [Related]

  • 17. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U, Bukan N, Sancak B, Günel N, Ozenirler S, Unal A, Yucel A.
    Neoplasma; 2004 May 30; 51(3):209-13. PubMed ID: 15254675
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF.
    Clin Cancer Res; 1997 Apr 30; 3(4):605-11. PubMed ID: 9815727
    [Abstract] [Full Text] [Related]

  • 19. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M, Takahashi S, Ogata E.
    Anticancer Res; 2003 Apr 30; 23(5b):4095-9. PubMed ID: 14666607
    [Abstract] [Full Text] [Related]

  • 20. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C, Stieber P, Untch M, Nagel D, Eiermann W, Fateh-Moghadam A.
    Anticancer Res; 1998 Apr 30; 18(2B):1243-9. PubMed ID: 9615795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.